An insight into the interplay between immune thrombocytopenic purpura (ITP) and heart failure: a retrospective analysis of national inpatient data in the United States

Background: Patients admitted with autoimmune thrombocytopenic purpura (ITP) tend to be high-risk individuals, primarily because of their susceptibility to bleeding and the constraints on potential medical interventions. Heart failure (HF) is a complex and widespread condition that significantly impairs quality of life. These patients face a multitude of respiratory and cardiovascular complications, compounded by the fact that they are often prescribed blood thinner medications which can exacerbate these risks. We analyzed the data to comprehensively understand the far-reaching impact and varied outcomes of underlying heart failure on patients diagnosed with autoimmune thrombocytopenic purpura.